Subfertility, FemaleNCT05137964
A Cross Sectional Evaluation of Vitamin D Status and Ovarian Reserve Markers
An observational study of Subfertility, Female, run by Australian Concept Medical Center.
Trial summary
Evaluation of the association between vitamin D (VD) deficiency and ovarian reserve markers in a group of Pakistani sub fertile women was conducted Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Subfertility, Female
- What is being tested?
- Vitamin D
- How many people
- 199 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2016to 1 Jul 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Adult
Study population: Pakistani female patients aged 18 to 45 years, presenting with primary and/or secondary subfertility
Who may be able to join
- Clinical diagnosis of primary and/or secondary subfertility
Who cannot join
- Patients with missing data i.e., BMI, duration of subfertility, age, AMH, 25-hydroxyvitamin D (25-OHD), AFC and FSH.
About this study
Official title: Is Vitamin D The Missing Piece of the Subfertility Puzzle in Pakistani Women? A Cross Sectional Evaluation of Vitamin D Status and Ovarian Reserve Markers
Evaluation of the association between vitamin D (VD) deficiency and ovarian reserve markers in a group of Pakistani sub fertile women was conducted
Read the detailed description
Objective
This study was conceived with the objective to assess ovarian reserves in presence of vitamin D deficiency (VDD) in a select group of Pakistani sub fertile women, presenting at a specialized fertility centre. The measurements of antral follicle count (AFC), Serum Anti-Müllerian hormone (AMH), Serum Follicle-stimulating hormone (FSH) and Serum Vitamin D (VD) levels were the main tools used for the assessment of ovarian reserve.
Materials \& Methods A retrospective cross-sectional study was conducted at the Australian Concept Medical Centre after approval from the institutional ethical review committee. All female patients aged 18 to 45 years, presenting with primary and/or secondary subfertility, at the Australian Concept Medical Centre in Karachi, Pakistan from August 2016 to July 2021 were included in the study (n=301). Inclusion criteria was focused on subjects labelled as sub fertile by the consultant gynecologist, based on the criteria of failed to conceive after 12 months of no contraceptive use. Patients with missing data i.e., BMI, duration of subfertility, age, AMH, 25-hydroxyvitamin D (25-OHD), AFC and FSH were further excluded.
The Biochemical analysis was performed at the section of Chemical Pathology, department of Pathology and Laboratory Medicine, Aga Khan University, Karachi. 25-OHD was analyzed by a chemiluminescence assay on the liaison XL (DiaSorin) analyzer. AMH was measured using electro chemiluminescence assay on the Roche Diagnostic e411 analyzer. While FSH quantification was done using ADVIA Centaur FSH assay from Siemens Medical Solutions Diagnostics USA. The internal and external quality assurance was ensured according to the institutional protocol. Moreover, the laboratory is accredited by the College of American Pathologists (CAP) and Joint Commission international, ensuring external quality assurance.
AFC was determined through a transvaginal 2D ultrasound of the pelvis. To reduce the bias, all ultrasound scans were conducted in the center using the same machine (Model 6v1: Sonoscape) and vaginal probe (3.5 Hz). Before ultra sound procedure, patients were directed to empty bladder and a standard ultrasound technique was used. Two values were obtained, one for each ovary, and an average was taken to obtain a final value.
The data of all eligible patients was recorded in the pre-defined Performa designed for this study. The Kruskal-Wallis Test and one way ANOVA was applied to report the distribution of the data. The correlation between the categorical variables (25-OHD levels with AFC and AMH) was assessed using the Chi-Square test and Spearman Correlation. Comparison was based on 25-OHD levels grouped into three categories: deficiency (<20ng/ml), insufficiency (21-29 ng/ml) and sufficiency (>30ng/ml). AMH was categorized as low (<1 ng/ml), low normal (1-2 ng/ml), normal (2-4 ng/ml), and high (>4 ng/ml). The third variable, AFC, was also classified into very low (<6), low normal (6-8), normal (8-10), high normal (10-12), very high (>12). The p value <0.05 was considered statistically significant. The statistical analysis was performed using the statistical software IBM SPSS Statistics for Windows version 23.0 (IBM Corp. Released 2015. Armonk, NY: IBM Corp).
- Conditions
- Subfertility, Female
- Being tested
- Vitamin D
- Keywords
- subfertile, female
- Medical subject headings
- Infertility, Female
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Vitamin DDiagnostic test
Also called Serum AMH, 25-hydroxyvitamin D (25-OHD), FSH and Antral Follicle Count (AFC) via ultra sound
Serum Biochemical routine lab workup and gynaecological ultra sound AFC
| Study group | Role | What they receive |
|---|---|---|
| Vitamin D Deficient | deficiency (<20ng/ml) Receives: Diagnostic Test: Vitamin D | |
| Vitamin D Sufficient | sufficiency (>30ng/ml) Receives: Diagnostic Test: Vitamin D |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation
To address gaps in local data, this study was conducted to explore the association between VDD and ovarian reserve, via measurements of AFC, AMH, FSH and 25-hydroxy vitamin D (25-OHD) in Pakistani women.
Measured: Aug 2016 to July 2021
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Nov 2021
- Study start1 Aug 2016
- Primary completion1 Jul 2021
- Study completion1 Jul 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Subfertility, FemaleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 199 participants (actual)
Sponsor and investigators
- Lead sponsor
- Australian Concept Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Uzma Imran, Australian Concept Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05137964
- Sponsor's protocol ID
- 2021-07-01-Uzma Imran
- Status last verified
- Nov 2021
- First submitted
- 5 Nov 2021
- Last updated
- 30 Nov 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is Vitamin D The Missing Piece of the Subfertility Puzzle in Pakistani Women? A Cross Sectional Evaluation of Vitamin D Status and Ovarian Reserve Markers
- ClinicalTrials.gov ID
- NCT05137964
- Acronym / sponsor ID
- 2021-07-01-Uzma Imran
- Conditions
- Subfertility, Female
- Keywords
- subfertile, female
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 199 participants (actual)
- Lead sponsor
- Australian Concept Medical CenterUniversity, hospital or other
- Study start
- 1 Aug 2016 (actual)
- Primary completion
- 1 Jul 2021 (actual)
- Study completion
- 1 Jul 2021 (actual)
- First posted
- 30 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluation of the association between vitamin D (VD) deficiency and ovarian reserve markers in a group of Pakistani sub fertile women was conducted
Detailed description
Objective
This study was conceived with the objective to assess ovarian reserves in presence of vitamin D deficiency (VDD) in a select group of Pakistani sub fertile women, presenting at a specialized fertility centre. The measurements of antral follicle count (AFC), Serum Anti-Müllerian hormone (AMH), Serum Follicle-stimulating hormone (FSH) and Serum Vitamin D (VD) levels were the main tools used for the assessment of ovarian reserve.
Materials \& Methods A retrospective cross-sectional study was conducted at the Australian Concept Medical Centre after approval from the institutional ethical review committee. All female patients aged 18 to 45 years, presenting with primary and/or secondary subfertility, at the Australian Concept Medical Centre in Karachi, Pakistan from August 2016 to July 2021 were included in the study (n=301). Inclusion criteria was focused on subjects labelled as sub fertile by the consultant gynecologist, based on the criteria of failed to conceive after 12 months of no contraceptive use. Patients with missing data i.e., BMI, duration of subfertility, age, AMH, 25-hydroxyvitamin D (25-OHD), AFC and FSH were further excluded.
The Biochemical analysis was performed at the section of Chemical Pathology, department of Pathology and Laboratory Medicine, Aga Khan University, Karachi. 25-OHD was analyzed by a chemiluminescence assay on the liaison XL (DiaSorin) analyzer. AMH was measured using electro chemiluminescence assay on the Roche Diagnostic e411 analyzer. While FSH quantification was done using ADVIA Centaur FSH assay from Siemens Medical Solutions Diagnostics USA. The internal and external quality assurance was ensured according to the institutional protocol. Moreover, the laboratory is accredited by the College of American Pathologists (CAP) and Joint Commission international, ensuring external quality assurance.
AFC was determined through a transvaginal 2D ultrasound of the pelvis. To reduce the bias, all ultrasound scans were conducted in the center using the same machine (Model 6v1: Sonoscape) and vaginal probe (3.5 Hz). Before ultra sound procedure, patients were directed to empty bladder and a standard ultrasound technique was used. Two values were obtained, one for each ovary, and an average was taken to obtain a final value.
The data of all eligible patients was recorded in the pre-defined Performa designed for this study. The Kruskal-Wallis Test and one way ANOVA was applied to report the distribution of the data. The correlation between the categorical variables (25-OHD levels with AFC and AMH) was assessed using the Chi-Square test and Spearman Correlation. Comparison was based on 25-OHD levels grouped into three categories: deficiency (<20ng/ml), insufficiency (21-29 ng/ml) and sufficiency (>30ng/ml). AMH was categorized as low (<1 ng/ml), low normal (1-2 ng/ml), normal (2-4 ng/ml), and high (>4 ng/ml). The third variable, AFC, was also classified into very low (<6), low normal (6-8), normal (8-10), high normal (10-12), very high (>12). The p value <0.05 was considered statistically significant. The statistical analysis was performed using the statistical software IBM SPSS Statistics for Windows version 23.0 (IBM Corp. Released 2015. Armonk, NY: IBM Corp).
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Vitamin D Deficient | – | Diagnostic Test: Vitamin Ddeficiency (<20ng/ml) |
| Vitamin D Sufficient | – | Diagnostic Test: Vitamin Dsufficiency (>30ng/ml) |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- Pakistani female patients aged 18 to 45 years, presenting with primary and/or secondary subfertility
Key inclusion criteria (1 listed)
- Clinical diagnosis of primary and/or secondary subfertility
Key exclusion criteria (1 listed)
- Patients with missing data i.e., BMI, duration of subfertility, age, AMH, 25-hydroxyvitamin D (25-OHD), AFC and FSH.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Vitamin DAlso: Serum AMH, 25-hydroxyvitamin D (25-OHD), FSH and Antral Follicle Count (AFC) via ultra soundSerum Biochemical routine lab workup and gynaecological ultra sound AFC | Diagnostic test | Vitamin D Deficient, Vitamin D Sufficient |
Primary outcome
Correlation
Time frame: Aug 2016 to July 2021
To address gaps in local data, this study was conducted to explore the association between VDD and ovarian reserve, via measurements of AFC, AMH, FSH and 25-hydroxy vitamin D (25-OHD) in Pakistani women.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Nov 2021.
- Individual participant dataSharing planned: No
Related trials for Subfertility, Female
RecruitingObservational study
Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms
Adenomyosis of Uterus
Not yet recruitingPhase 3
Progesterone Luteal Support in Unexplained Infertility Management
Infertility, Female Infertility
RecruitingObservational study
The FLORA-project: in Search for the Microbial Cause of Chronic Endometritis and the Most Appropriate Treatment to Obtain a Successful Pregnancy IVF/ICSI
Endometritis; Chronic, Subfertility
RecruitingObservational study
The (Cost-)Effectiveness of Surgical Excision of Colorectal Endometriosis Compared to ART Treatment Trajectory
Endometriosis, Rectum, Endometriosis of Colon
Recruiting
Innovation for Small-scale Experiments: ReceptIVFity Test
Pregnancy Related, Infertility, Female
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Subfertility, Female, run by Australian Concept Medical Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation (time frame: Aug 2016 to July 2021). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2021.